{"blog": [], "keywords": [{"value": "Conflicts of Interest", "name": "subject", "rank": "1", "is_major": "Y"}, {"value": "Boies, David", "name": "persons", "rank": "2", "is_major": "Y"}, {"value": "Theranos Inc", "name": "organizations", "rank": "3", "is_major": "Y"}, {"value": "Holmes, Elizabeth (1984- )", "name": "persons", "rank": "4", "is_major": "N"}, {"value": "Boies, Schiller & Flexner LLP", "name": "organizations", "rank": "5", "is_major": "N"}, {"value": "Tests (Medical)", "name": "subject", "rank": "6", "is_major": "N"}, {"value": "Venture Capital", "name": "subject", "rank": "7", "is_major": "N"}, {"value": "Boards of Directors", "name": "subject", "rank": "8", "is_major": "N"}], "web_url": "http://www.nytimes.com/2016/02/03/business/dealbook/david-boiess-dual-roles-at-theranos-set-up-conflict.html", "document_type": "article", "byline": {"person": [{"middlename": "Davidoff", "firstname": "Steven", "role": "reported", "rank": 1, "lastname": "SOLOMON", "organization": ""}], "original": "By STEVEN DAVIDOFF SOLOMON"}, "type_of_material": "News", "multimedia": [{"url": "images/2016/02/03/business/03db-dealprofillo-web/03db-dealprofillo-web-thumbWide.jpg", "legacy": {"wide": "images/2016/02/03/business/03db-dealprofillo-web/03db-dealprofillo-web-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "subtype": "wide", "type": "image", "width": 190, "height": 126}, {"url": "images/2016/02/03/business/03db-dealprofillo-web/03db-dealprofillo-web-articleLarge.jpg", "legacy": {"xlarge": "images/2016/02/03/business/03db-dealprofillo-web/03db-dealprofillo-web-articleLarge.jpg", "xlargeheight": "605", "xlargewidth": "600"}, "subtype": "xlarge", "type": "image", "width": 600, "height": 605}, {"url": "images/2016/02/03/business/03db-dealprofillo-web/03db-dealprofillo-web-thumbStandard.jpg", "legacy": {"thumbnail": "images/2016/02/03/business/03db-dealprofillo-web/03db-dealprofillo-web-thumbStandard.jpg", "thumbnailheight": "75", "thumbnailwidth": "75"}, "subtype": "thumbnail", "type": "image", "width": 75, "height": 75}], "section_name": "Business Day", "word_count": "1095", "source": "The New York Times", "subsection_name": "DealBook", "lead_paragraph": "Mr. Boies represents Theranos as its lawyer, but he also represents the company\u2019s investors as a director, a situation that could become tricky.", "pub_date": "2016-02-03T00:00:00Z", "news_desk": "Business", "headline": {"kicker": "Deal Professor", "print_headline": "Star Lawyer&#8217;s Dual Roles at Theranos Set Up Conflict", "main": "David Boies\u2019s Dual Roles at Theranos Set Up Conflict", "content_kicker": "Deal Professor"}, "print_page": "5", "snippet": "Mr. Boies represents Theranos as its lawyer, but he also represents the company\u2019s investors as a director, a situation that could become tricky.", "_id": "56b0f48c38f0d873ef2950af", "slideshow_credits": null, "abstract": "Steven Davidoff Solomon Deal Professor column questions wisdom of star lawyer David Boies, who has assumed dual roles of director and lawyer for embattled medical testing company Theranos."}